Cited by 15Genetic factors in colorectal cancerCancer Genomics and DiagnosticsColorectal Cancer Screening and Detection

Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients

Open access
Terlouw, Diantha, Boot, Arnoud, Ducarmon, Quinten R., Nooij, Sam, Suerink, Manon, van Leerdam, Monique E., van Egmond, Demi, Tops, Carli M. +6 more·2024·BMC Cancer

Published version of a preprint

Abstract

Background: Colibactin, a genotoxin produced by polyketide synthase harboring ( pks + ) bacteria, induces double-strand breaks and chromosome aberrations. Consequently, enrichment of pks + Escherichia coli in colorectal cancer and polyposis suggests a possible carcinogenic effect in the large intestine. Additionally, specific colibactin-associated mutational signatures; SBS88 and ID18 in the Catalogue of Somatic Mutations in Cancer database, are detected in colorectal carcinomas. Previous research showed that a recurrent APC splice variant perfectly fits SBS88. Methods: In this study, we explore the presence of colibactin-associated signatures and fecal pks in an unexplained polyposis cohort. Somatic targeted Next-Generation Sequencing (NGS) was performed for 379 patients. Additionally, for a subset of 29 patients, metagenomics was performed on feces and mutational signature analyses using Whole-Genome Sequencing (WGS) on Formalin-Fixed Paraffin Embedded (FFPE) colorectal tissue blocks. Results: NGS showed somatic APC variants fitting SBS88 or ID18 in at least one colorectal adenoma or carcinoma in 29% of patients. Fecal metagenomic analyses revealed enriched presence of pks genes in patients with somatic variants fitting colibactin-associated signatures compared to patients without variants fitting colibactin-associated signatures. Also, mutational signature analyses showed enrichment of SBS88 and ID18 in patients with variants fitting these signatures in NGS compared to patients without. Conclusions: These findings further support colibactins ability to mutagenize colorectal mucosa and contribute to the development of colorectal adenomas and carcinomas explaining a relevant part of patients with unexplained polyposis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-024-11849-y

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • E. coli Nissle 1917 synthesizes and releases colibactin, a mutagenic substance that promotes colorectal polyposis and cancer and reduces cancer response to irinotecan.

    “having the capability of synthetizing and releasing colibactin, a mutagenic substance described to promote colorectal polyposis and cancer, and reducing cancer response to irinotecan [26, 34–39].”

    From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [38]

    The Background (page not provided) says pks-harboring E. coli can produce the genotoxin colibactin, and the Discussion links colibactin-associated signatures to colorectal lesions. The copy does not identify E. coli Nissle 1917, establish that it releases colibactin, or address response to irinotecan. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • E. coli Nissle 1917 is pks-positive.

    “the most widely used E. coli-based probiotic, known as E. coli Nissle 1917 (DSM 6601), is pks-positive.”

    From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [38]

    The Background discusses pks-bearing E. coli generally, and the Results report pks genes in patient fecal samples. Neither identifies E. coli Nissle 1917 as pks-positive. Searches for “Nissle 1917” and “DSM 6601” found no passage addressing that strain. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Terlouw, D., Boot, A., Ducarmon, Q. R., Nooij, S., Suerink, M., van Leerdam, M. E., van Egmond, D., Tops, C. M., Zwittink, R. D., Ruano, D., Langers, A. M. J., Nielsen, M., van Wezel, T., & Morreau, H.
Affiliations
  • Leiden University Medical Center (NL)
  • National University of Singapore (SG)
Corresponding author
Morreau, Hans
Venue
BMC Cancer
Published
2024-01-18
Volume
24
Issue
1
Pages
104-104
ISSN
1471-2407 (ISSN-L)
OpenAlex
W4390974659
Cited by
15
References
30
Citations by year
2026: 8 · 2025: 5 · 2024: 2
FWCI
4.56
Type
journal article
Language
en
Open access
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
KWF Kankerbestrijding (11292)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Keywords
colibactin, mutational signatures, colorectal polyposis, colorectal adenoma, colorectal cancer, PKS genes, fecal microbiota, Escherichia coli, somatic mutations, colorectal carcinogenesis
MeSH terms
Adenoma, Carcinoma, Escherichia coli, Humans, Mutation, Peptides, Colorectal Neoplasms, Polyketides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review